Assertio Holdings, Inc. (ASRT)
11.84
-0.22
(-1.82%)
USD |
NASDAQ |
Feb 20, 16:00
11.40
-0.44
(-3.72%)
After-Hours: 20:00
Assertio Holdings SG&A Expense (Quarterly) : 10.74M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alkermes Plc | 171.77M |
| Altimmune, Inc. | 5.904M |
| Verastem, Inc. | 21.01M |
| Actinium Pharmaceuticals, Inc. | 1.534M |
| Ultragenyx Pharmaceutical, Inc. | 89.00M |